
Sign up to save your podcasts
Or


Will gene therapy companies produce healthy returns for investors? Ron Gross explains why he’s investing in gene therapy companies and shares his big question for the year ahead.
By The Motley Fool4.7
16041,604 ratings
Will gene therapy companies produce healthy returns for investors? Ron Gross explains why he’s investing in gene therapy companies and shares his big question for the year ahead.

3,221 Listeners

1,499 Listeners

806 Listeners

950 Listeners

523 Listeners

1,177 Listeners

2,170 Listeners

826 Listeners

1,418 Listeners

1,040 Listeners

9,628 Listeners

192 Listeners

810 Listeners

76 Listeners

563 Listeners

984 Listeners

44 Listeners